−7.51USD
−175.77 MUSD
202.57 MUSD
16.22 M
About GeneDx Holdings Corp.
Sector
Industry
CEO
Katherine A. Stueland
Website
Headquarters
Stamford
Employees (FY)
1 K
Founded
2015
FIGI
BBG00XDHY5P9
GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of WGS is 11.82 USD — it has decreased by 1.50% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange GeneDx Holdings Corp. stocks are traded under the ticker WGS.
GeneDx Holdings Corp. is going to release the next earnings report on Apr 29, 2024. Keep track of upcoming events with our Earnings Calendar.
WGS stock is 8.60% volatile and has beta coefficient of 1.15. Check out the list of the most volatile stocks — is GeneDx Holdings Corp. there?
WGS earnings for the last quarter are −0.82 USD per share, whereas the estimation was −1.31 USD resulting in a 37.36% surprise. The estimated earnings for the next quarter are −0.65 USD per share. See more details about GeneDx Holdings Corp. earnings.
GeneDx Holdings Corp. revenue for the last quarter amounts to 53.30 M USD despite the estimated figure of 52.42 M USD. In the next quarter revenue is expected to reach 54.24 M USD.
Yes, you can track GeneDx Holdings Corp. financials in yearly and quarterly reports right on TradingView.
WGS stock has risen by 22.23% compared to the previous week, the month change is a 37.44% rise, over the last year GeneDx Holdings Corp. has showed a 25.58% increase.
WGS net income for the last quarter is −25.77 M USD, while the quarter before that showed −42.29 M USD of net income which accounts for 39.05% change. Track more GeneDx Holdings Corp. financial stats to get the full picture.
Today GeneDx Holdings Corp. has the market capitalization of 307.95 M, it has increased by 8.12% over the last week.
No, WGS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, WGS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GeneDx Holdings Corp. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 1.00 K employees. See our rating of the largest employees — is GeneDx Holdings Corp. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GeneDx Holdings Corp. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GeneDx Holdings Corp. stock shows the buy signal. See more of GeneDx Holdings Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on GeneDx Holdings Corp. future price: according to them, WGS price has a max estimate of 15.00 USD and a min estimate of 5.50 USD. Read a more detailed GeneDx Holdings Corp. forecast: see what analysts think of GeneDx Holdings Corp. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GeneDx Holdings Corp. EBITDA is −127.69 M USD, and current EBITDA margin is −63.10%. See more stats in GeneDx Holdings Corp. financial statements.